DEFA14A: Amgen Inc. to Hold 2024 Annual Meeting of Stockholders Virtually
Proxy Statement
Amgen Inc. will hold its 2024 Annual Meeting of Stockholders virtually on May 31, 2024, with stockholders voting on the election of directors, executive compensation, an equity incentive plan, and the ratification of the company's independent auditor.
Summary
- Amgen Inc. will conduct its 2024 Annual Meeting of Stockholders virtually on May 31, 2024.
- Stockholders of record as of April 1, 2024, are eligible to vote.
- The meeting will address the election of twelve directors, an advisory vote on executive compensation, approval of the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan, and ratification of Ernst & Young LLP as the independent registered public accountants for the fiscal year ending December 31, 2024.
- Stockholders can access meeting materials and vote online at www.ProxyVote.com.
- The deadline to vote shares held directly is May 30, 2024, at 11:59 PM ET, while the deadline for shares held in Amgen-sponsored plans is May 28, 2024, at 11:59 PM ET.
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, presenting neutral information about the upcoming annual meeting. The sentiment is moderately positive as it facilitates shareholder participation and corporate governance.
Positives
- The virtual format of the annual meeting allows for broader participation from stockholders.
- Stockholders have multiple options to access meeting materials and vote, including online, by phone, and by email request.
- The agenda includes important governance matters such as director elections and executive compensation.
Future Outlook
The document outlines the agenda and procedures for the upcoming annual meeting, focusing on key governance matters and providing stockholders with the opportunity to vote on important proposals.
Industry Context
Virtual shareholder meetings have become increasingly common, reflecting a broader trend towards digital communication and increased accessibility for investors.
Stakeholder Impact
- Shareholders can participate in key decisions regarding the company's governance and direction.
- The outcome of the votes on director elections and executive compensation will impact the company's leadership and management incentives.
Next Steps
- Stockholders should review the proxy materials and vote on the proposals by the specified deadlines.
- Amgen will hold the virtual annual meeting on May 31, 2024.
Key Dates
| Date | Description |
|---|---|
| April 1, 2024 | Record date for voting eligibility |
| May 17, 2024 | Deadline to request a paper or email copy of the proxy materials |
| May 28, 2024 | Voting deadline for shares held in Amgen-sponsored plans (11:59 PM ET) |
| May 30, 2024 | Voting deadline for shares held directly (11:59 PM ET) |
| May 31, 2024 | Date of the 2024 Annual Meeting of Stockholders (11:00 A.M. Pacific Time) |
| December 31, 2024 | Fiscal year end for which Ernst & Young LLP is being ratified as the independent auditor |
Keywords
Annual Meeting, Stockholders, Proxy Vote, Amgen, Directors, Executive Compensation, Equity Incentive Plan, Ernst & Young, Auditors
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.